Design and analysis of in vitro experiments for combination chemotherapy

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 1, 2005, Pages 179-186

  Le, Chap T ^a   Grambsch, Patricia M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Combination chemotherapy; Drug potency; Isobologram; Synergism

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RESEARCH; DEVICE; DOSE RESPONSE; DRUG EFFECT; EVALUATION; EXPERIMENTAL DESIGN; IN VITRO STUDY; ISOBOLOGRAM; LINEAR REGRESSION ANALYSIS; LOGISTIC REGRESSION ANALYSIS; METHODOLOGY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; LINEAR MODELS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; RESEARCH DESIGN;

EID: 12344302523     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-200040857     Document Type: Article

References (17)

1. Akutsu, M., Furukawa, Y., Tsunoda, S., Izumi, T., Ohmine, K., Kano, Y. (2002). Schedule-dependent synergism and antogonism between methotrexate and cytarabine against human leukemia cell lines in vitro. Leukemia 16:1808-1817.
2. Armtage, P. (1977). Statistical Methods in Medical Research. New York: John Wiley and Sons.
3. Ashton, W. D. (1972). The Logit Transformation. New York: Hafner Publishing Co.
4. Carter, W. H. Jr. (1995). Relating isobolograms to response surfaces. Toxicology 105:181-188.
5. Chou, T. C. (1976). Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands. J. Theor. Biol. 59:233-276.
6. Chou, T. C., Talalay, P. (1977). A simple generalized equation for the analysis of multiple inhibitions of Michaelis-Menten kinetic systems. J. Biol. Chem. 252:6438-6442.
7. Chou, T. C., Talalay, P. (1983). Analysis of combined drug effects: A new look at a very old problem. Trends Pharmacol. Sci. 4:450-454.
8. Gessner, P. K. (1995). Isobolographic analysis of interactions: An update on applications and utility. Toxicology 105:161-179.
9. Hamilton, M. A. (1979). Robust estimates of the ED50. J. Amer. Statist. Assoc. 74:344-354.
10. Kano, Y., Ohnuma, T., Okano, T., Holland, J. F. (1988). Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture. Cancer Res. 48:351-356.
11. Loewe, S. (1953). The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285-290.
12. Loewe, S. (1957). Antagonism and antogonists. Pharmocol. Rev. 9:237-242.
13. Nishizaki, M., Meyn, R. E., Levy, L. B., Atkinson, E. N., White, R. A., Ji, L. (2001). Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo. Clin. Cancer Res. 7:2887-2897.
14. Steel, G. G. (1979). Terminology in the description of drug-radiation interactions. Int. J. Radiat. Oncol. 5:1145-1150.
15. Steel, G. G., Peckham, M. J. (1979). Exploitable mechanisms in combined radiotherapy-chemotherapy: The concept of additivity. Int. J. Radiat. Oncol. 5:85-91.
16. Tallarida, R. J. (2000). Drug Synergism and Dose-Effect Data Analysis. New York: Chapman & Hall/CRC.
17. Tallarida, R. J., Raffa, R. B. (1996). Testing for synergism over a range fixed-ratio drug combinations: Replacing the isobologram. Life Sci. 58:PL23-28.